Sanofi is utilizing artificial intelligence to transform its operations, including drug discovery and disease detection. The company is investing in its ai capabilities, including a hub in Toronto, and has partnered with other organizations, such as Recursion and Pangaea, to leverage ai in various areas. The scope and details of these efforts vary, with reports indicating a range of initiatives aimed at scaling ai use in healthcare and medicine.